NASDAQ:ARWR

Arrowhead Pharmaceuticals Earning Date

USA |NASDAQ |USD

ARWR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 22, 2021 Sep 2021 $-0.10 $-0.29 $-0.48
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 22, 2021 Sep 2021 $56.78M $45.89M $7.63M

Arrowhead Pharmaceuticals's next earnings date is Monday, Nov 22, 2021 for the fiscal quarter ending Sep 2021.

ARWR Earnings Date & History Chart

ARWR Earnings & Revenue Forecast

ARWR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.47 $-0.71 $-0.31
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 12 $-0.48 $-1.98 $1.89

ARWR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.47 $-0.47 $-0.36
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 0 / 0 $-0.48 $-0.52 $-0.30

ARWR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $28.17M $11.00M $42.90M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 12 $240.82M $132.20M $469.70M

ARWR Earnings Date & Revenue History

ARWR Earnings History

|
Show More
Show More

ARWR Revenue History

|
Show More
Show More

Arrowhead Pharmaceuticals Next Earnings Date & Report

ARWR Next Earnings Date & Report Preview: Sep 2021 (FQ)

ARWR's next earnings date is Monday, Nov 22, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 11 analysts, the average EPS estimation for Arrowhead Pharmaceuticals's next quarterly earnings is $-0.10, with a low EPS estimation of $-0.50, and a high estimation of $1.17.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.10, the last 2 month trend is $-0.06, and the 3 month trend is $-0.20.

Based on 11 analysts, the average revenue estimation is $56.78M, with a low revenue estimation of $25.00M, and a high estimation of $202.67M.

Arrowhead Pharmaceuticals Previous Earnings Dates & Reports

ARWR Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Arrowhead Pharmaceuticals's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

ARWR's earnings per share (EPS) was $-0.29, missing the consensus analysts forecast of $-0.14 by -108.33%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 11.54%, and lower than the same period a year before (Jun 2020) by 123.08%.

Revenues were $45.89M, better than the forecast of $37.52M by 22.31%, up by 39.86% from the previous quarter , and up by 67.63% from the same period last year.

The company reported a net income of $-29.92M.

Free cash flow for the quarter was $-33.54M , compared to $256.71M last quarter and $-35.57M a year before.

ARWR ended the quarter with $24.14M in total debt, an increase of 1.45% compared to the previous quarter, and an increase of 12.97% compared to the same quarter a year before.

ARWR Previous Earnings Date & Report Recap: Sep 2020 (FY)

Arrowhead Pharmaceuticals's previous annual earnings date was Nov 23, 2020 for its fiscal year ended Sep 30, 2020.

ARWR's earnings per share (EPS) was $-0.84, missing the consensus analysts forecast of $-0.21 by 300.00% , and lower than the previous year's EPS (Sep 2019) by -221.74%.

Revenues were $87.99M, worse than the forecast of $129.53M by -32.07%, and down by -47.87% from previous year's revenue.

The company reported a net income of $-84.55M.

Arrowhead Pharmaceuticals reported a free cash flow of $-107.34M for its fiscal year, compared to $161.03M a year ago.

The company ended the fiscal year with $21.14M in total debt. lala